当前位置:药药网 / 药品研发 / 美国药品上市后承诺数据库
VEKLURY (remdesivir)
药品名称
VEKLURY (remdesivir)
承诺描述
Conduct a study to evaluate the safety, tolerability, pharmacokinetics, and treatment response to remdesivir in pediatric subjects from birth to less than 18 years of age including neonates, with coronavirus disease 2019 (COVID-19).
承诺状态描述
The study has not been initiated, but it does not meet the criterion for delayed.